I argued as follows:

Ironically, in the long run, hiding the influence of Big Pharma on smoking cessation policy does not advance the cessation field, but brings it to a grinding halt. The public, and tobacco control practitioners themselves, need to understand the deeply ingrained roots of Big Pharma within the tobacco control movement, especially in the smoking cessation field. Failure to do so will lead to blind following of an industry-based agenda. This is precisely what has happened in tobacco control.

In a grant proposal that was subsequently funded by the state of California's Tobacco-Related Disease Research Program (TRDRP), Dr. Manuela Martin-Greens and colleagues from the University of California, Riverside exhibited their fortune-telling skills, claiming to know the results of their proposed lab experiments on mice before actually performing the studies.

Nevertheless, the anti-smoking groups insist that the tobacco industry funding should have been disclosed. For one, they argue that section 5 of the form insists that authors disclose any other conflicts of interest, even if they occurred prior to the past three years. Second, they argue that the history of funding by tobacco companies is well within the spirit of the disclosure requirement and that the authors have an obligation to let readers know that in the past, they have had financial relationships with Big Tobacco.

LAST：China Ego Vaporizer Manufacturer Factory Exporter Supply Ego Vaporizer Bulk E Cigarette Purchase |NEXT：Promoation!!!! China Alibaba most popular ecigator ecig e smart pcc